FGFR2 and breast carcinoma: Therefore, we tried to assess the impact of FGFR2 intron 2 polymorphisms (rs2981582, rs1219648, rs2981578 and rs7895676) on sporadic breast cancer and determined their association with the risk for North Indian women in a case control approach, including combined effect of these variants, LD structure measurement, haplotype analysis, as well as relation with patients' clinical, environmental and lifestyle characteristics.